In fish the terminal nerve is comprised of a group of cells with somata adjacent to the olfactory bulb and processes that extend both anteriorly to the olfactory mucosa and posteriorly to the telencephalon. In teleost fish an additional group of axons extends along the optic tract and delivers putative neuromodulators to the retina. One peptide -gonadotropin-releasing hormone (GnRH) -has been implicated as a prime candidate neuromodulator based on electrophysiological evidence that exogenous application influences neural activity. Here we describe the expression patterns of two GnRH receptor subtypes in the retina of a teleost fish, Astatotilapia (Haplochromis) burtoni. The type 1 GnRH receptor (GnRH-R1) was expressed in cells of the amacrine cell layer -where lateral inputs affect the flow of visual information from photoreceptors to the brain -and in a distribution and location pattern similar to dopaminergic interplexiform cells. Immunohistochemical labeling of GnRH fibers revealed varicosities along terminal nerve axons near the amacrine cell layer and near cells immunoreactive for tyrosine hydroxylase, a dopaminergic cell marker. This finding supports an existing model that the terminal nerve forms synapses with dopaminergic interplexiform cells. Surprisingly, the type 2 GnRH receptor (GnRH-R2) was abundantly expressed in ganglion cells, which lie along the direct pathway of visual information to the brain. These data suggest that GnRH from the TN could broadly influence processing of retinal signals both in lateral processing circuits through GnRH-R1 and in the vertical throughput pathway through GnRH-R2.
Introduction
Although described in every class of vertebrates [see Demski, 1993 for review] with few exceptions [Eisthen and Northcutt, 1996] , little is understood about the function of the 0th cranial or 'terminal' nerve. The terminal nerve (TN) was originally thought to participate in sensory functions based on lesion studies and its conspicuous anatomical relationship to olfactory and visual processing areas [Demski and Northcutt, 1983] . Now the TN is viewed as a neuromodulator of forebrain, retinal, and olfactory information processing [Oka, 1992; Eisthen et al., 2000] . Typically in fish the TN has cell bodies located near the olfactory bulb and sends central processes into the telencephalon and peripheral processes toward the olfactory mucosa, although its precise anatomy varies widely among species [Demski, 1984] . Where described in teleost fish, TN cell axons travel with the optic nerve and arborize in the inner plexiform layer of the retina [Munz et al., 1982; Stell et al., 1984] . Retinal projections of the TN have also been reported for the northern leopard frog [Wirsig-Wiechmann and Basinger, 1988] , although the neuroanatomy in this species is less well characterized.
By convention, the terminal nerve is identified by its location and by its immunoreactivity to gonadotropinreleasing hormone [GnRH, also called luteinizing-hormone releasing hormone (LHRH)]. There are several forms of GnRH expressed in the brains of vertebrate species, each encoded by distinct genes and referred to as class 1, 2, or 3 [Fernald and White, 1999] . In each species, the particular peptide sequence varies, but the anatomical location and some functions are conserved. GnRH1 is the signaling peptide used by neurons that project from the forebrain to the pituitary where it regulates gonadotropin release [White et al., 1995] . GnRH2 is found in the midbrain near the fourth ventricle [White et al., 1995] and has been shown to act as a neuromodulator in spinal neurons [Jan et al., 1980] . A third form, GnRH3, is localized in the terminal nerve [White et al., 1995; Dubois et al., 2002] .
The teleost retina is an ideal system in which to study TN function; cell types are readily identifiable and connections between cell layers have been described in great detail [see fig. 1A for a schematic of the teleost retina; Dubin, 1974] . Electron microscopic images have shown that GnRH-immunoreactive fibers of the TN synapse on dopaminergic cells of the goldfish retina [Zucker and Dowling, 1987] . These dopaminergic interplexiform cells comprise about 1% of cells in the amacrine cell layer of goldfish [Marc, 1982] and send processes distally to the outer plexiform layer and proximally to the inner plexiform layer [Dowling and Ehinger, 1978] . Others have found evidence of TN fibers adjacent to ganglion, bipolar, amacrine, and horizontal cells [Stell et al., 1984; Ball et al., 1989; Malz et al., 1999] .
Although no published reports have described electrophysiological recordings from dopaminergic cells during application of GnRH, horizontal and ganglion cells have been investigated and implicated as possible targets because they show electrical responses to GnRH application. Walker and Stell [1986] recorded from retinal ganglion cells in the goldfish and found that GnRH was usually excitatory. Based on anatomical connections and the effects that peptides had during light responses, the researchers proposed that amacrine and possibly horizontal cells are targets of neuromodulators released from the TN, although they could not exclude ganglion cells as well. Umino and Dowling [1991] provided further electrophysiological evidence that GnRH from the terminal nerve affects dopaminergic and possibly amacrine cells. Their recordings from horizontal cells showed that GnRH application mimicked the action of dopamine. Because the interplexiform cells are thought to be the only dopaminergic cells in the goldfish retina [Dowling and Ehinger, 1978] , this suggested that GnRH from the TN elicits dopamine release by directly acting on dopaminergic cells or indirectly via amacrine cells.
Electrophysiological recordings support the idea that GnRH can modulate retinal activity but, due to the interconnected nature of the retina, it has not been possible to identify specifically where and how GnRH acts. To understand how GnRH might act on retinal circuitry, we need to know where GnRH receptors are located. We have previously shown that the teleost fish Astatotilapia (Haplochromis) burtoni possesses two types of GnRH receptors, type 1 and type 2 [Robison et al., 2001; Au et al., 2003] . Lethimonier et al. [2004] provided a basis for characterizing GnRH receptors as type 1 or type 2 based on predicted molecular phenotypes, and A. burtoni has been shown to express GnRH-receptor type 2 (GnRH-R2; note that Lethimonier and colleagues list this receptor in A. burtoni as GnRH-R1) in the retina [Robison et al., 2001] . Madigou et al. [2000] also reported finding a type 2 GnRH receptor in the retina of rainbow trout (Oncorhynchus mykiss). The expression of the type 1 receptor in the retina has not yet been described. To establish which receptors are responsible for detecting GnRH3 from the TN and which cell types could respond to GnRH3, we performed in situ hybridization to the type 1 and type 2 GnRH receptor mRNA in the A. burtoni retina. We also localized GnRH-expressing terminal nerve fibers in A. burtoni using immunohistochemistry. Our findings illuminate the pathways employed by GnRH3 to affect visual processing in the retina and provide a foundation for further studies of such modulation. Furthermore, these results lend insight into GnRH ligand-receptor relationships.
Materials and Methods
To identify potential retinal targets of GnRH from the terminal nerve we (1) examined the location of GnRH immunoreactivity in the retina and (2) localized GnRH receptors to specific retinal cell types. For the first study, we labeled TN fibers with an antibody to GnRH3 and, because TN fibers and dopaminergic cells are thought to form synaptic connections [Zucker and Dowling, 1987] , we performed a double antibody stain with GnRH3 and tyrosine hydroxylase (TH), a dopaminergic cell marker. Although TH labels all catecholaminergic cells, only dopaminergic cells have been identified in fish retinas [Dowling and Ehinger, 1978] ; therefore we will refer to TH-positive cells as dopaminergic. For the second study we performed in situ hybridization to detect mRNA of GnRH receptor subtypes 1 and 2 in retinal sections.
Tissue Preparation
Reproductively active male A. burtoni were selected from a general laboratory population derived from a wild-caught stock. All handling of fish was in accordance with the policies of the Stanford University Administrative Panel on Laboratory Animal Care. Animals were killed by rapid cervical transection and enucleated eyes were placed in sterile phosphate-buffered saline (PBS). The cornea, lens, and in some cases sclera were removed and the vitreous humour digested by a 5 min incubation in 200 U/ml hyaluronidase in PBS. Eyes used for immunohistochemistry on retinal sections were fixed overnight in 4% paraformaldehyde at 4°C, cryoprotected in 30% sucrose with 0.02% sodium azide for 24 h, embedded in OCT Compound (Tissue-Tek, Torrence, Calif., USA), and stored at -80°C until they were serially sectioned at 20 Ìm using a cryostat and thawmounted onto slides (Superfrost, Fisher, Santa Clara, Calif., USA). Eyes used for immunohistochemistry on whole retinas were dissected and fixed as above and an additional dissection was performed to remove the cornea, iris, sclera, choroid and pigmented epithelium [Zygar et al., 1999] , and retinal cups were stored at 4°C in PBS until use. Eyes used for in situ hybridization were immediately embedded after vitreous digestion, flash-frozen and stored at -80°C until they were serially sectioned at 14 Ìm on a cryostat and thaw-mounted onto glass slides (Superfrost, Fisher, Santa Clara, Calif., USA). Slides were stored at -80°C until use.
Immunohistochemistry
Immunohistochemistry was performed on both retinal sections and whole-mounted retinas in order to locate GnRH3-containing TN fibers. Immunohistochemical processing of retinal sections was as follows: 5 min in phosphate buffered saline (PBS), 5 min in PBS supplemented with 0.2% bovine serum albumin and 0.2% Triton X-100 (PBT), 1 h in PBT with 5% normal goat serum (Pel-Freeze, Rogers, Ark., USA), overnight incubation with primary antibody diluted 1:1000 in PBT with 5% normal goat serum at 4°C. Primary antibody was generously provided by Dr. Kobayashi (University of Tokyo) and is a polyclonal rabbit antibody against [Trp 7 ][Leu 8 ]-GnRH, which is the GnRH3 form in A. burtoni [White et al., 1995] . Following primary antibody incubation, slides were washed four times for 15 min each in PBT and incubated at room temperature for 2 h with biotinylated anti-rabbit antibody diluted 1:200 in PBT (Vector Laboratories, Burlingame, Calif., USA). Slides were then washed four times for 15 min each in PBT and incubated at room temperature for 2 h with Texas Red-conjugated avidin diluted 1:200 in PBS (Vector Laboratories) and Hoechst 33342 diluted 1:1000 for nuclear staining (Sigma, St. Louis, Mo., USA). Slides were washed in PBS and coverslipped in Fluoromount-G mounting media (Southern Biotechnology Association, Birmingham, Ala., USA). For whole-mounted retinas, the steps were performed in vials with incubations and reagents as described above, except that antibody incubation times were increased and Triton X-100 was used at a concentration of 0.5% instead of 0.2%. Following the procedure, several slits were made in the eye cup so that the retina could be mounted flat on a microscope slide [Zygar et al., 1999] .
To locate dopaminergic interplexiform cells we immunostained for tyrosine hydroxylase (TH) alone and in combination with GnRH immunohistochemistry. The single TH antibody stain procedure was performed as above, except for the following modifications: primary antibody was monoclonal mouse anti-TH diluted 1:500 (Chemicon, Temecula, Calif., USA), secondary antibody was peroxidase-conjugated anti-mouse (Vector Laboratories), and fluorescent conjugate was added using tyramide signal amplification as follows. Briefly, following secondary incubation, slides were washed twice in PBT, incubated for 10 min in fluorescein tyramide reagent diluted 1:50 in amplification diluent (TSA Direct Kit, Perkin Elmer, Wellesley, Mass., USA), washed twice in PBT and then incubated with the nuclear stain Hoechst 33343 as above. For detection of both TH and GnRH, the primary and secondary antibodies were simply combined. For the TH stain in whole retinas, the secondary antibody was biotinylated anti-mouse and the tertiary was Texas Red-conjugated avidin, both diluted 1:200 (Vector Laboratories). Double staining was not performed in whole retinas.
In situ Hybridization
Templates for radioactively labeled RNA probes specific for GnRH receptor types I and II were generated using polymerase chain reaction (PCR). Primers specific to each GnRH receptor subtype were designed from known sequences of GnRH receptors in A. burtoni [GnRH-R1 GenBank Accession No. AF356598; GnRH-R2 GenBank Accession No. AY028476; note that the names of these sequences have changed to conform to the suggestions of Lethimonier et al., 2004] : primers for GnRH-R1: 5)-AATGAACGCCTC-TCTGTGTGACCCTGC and 5)-GCCCAGCAGGTAGTATGGA-GTCCAGCA; primers for GnRH-R2: 5)-AGAACAGAGGAGTCC-GACCTGAGGCG and 5)-TGGTTGTTGGTGGAGGGCTGCG. Pituitary RNA was extracted and reverse transcribed using standard techniques and used for template amplification in a PCR Express Thermocycler (Hybaid, Waltham, Mass., USA). We used the Advantage-GC PCR Polymerase Mix (BD Biosciences, Palo Alto, Calif., USA) for PCR. An 800 bp PCR product for GnRH-R1 and an 1,100 bp product for GnRH-R2 were cloned into the pCRII-TOPO vector using the TOPO TA Cloning Kit (Invitrogen, Carlsbad, Calif., USA). Plasmids from selected bacterial colonies were excised using a QIAspin MiniPrep Kit (QIAGEN, Valencia, Calif., USA) and sequenced. Plasmids were linearized using Bam HI and Xho I to generate both sense and antisense templates for each receptor and cleaned via QIAquick PCR Purification Kit (QIAGEN, Valencia, Calif., USA). Radioactive sense and antisense RNA probes were prepared using in vitro transcription with SP6 or T7 polymerase and 35 S-UTP according to manufacturer's directions (Maxiscript kit, Ambion, Austin, Tex., USA).
Retinal tissue slides were prepared for hybridization by a 10 min fixation in 4% paraformaldehyde in PBS, rinsed twice for 3 min each in PBS, immersed in 0.1 M triethanolamine (TEA) buffer for 3 min, acetylated in 0.25% acetic anhydride in 0.1 M TEA for 10 min, rinsed twice for 3 min each in 2! sodium citrate sodium chloride (SSC) buffer, dehydrated in an ethanol series, and air dried. Probes were diluted to 5 ! 10 6 cpm/ml in hybridization buffer (SigmaAldrich, St. Louis, Mo., USA) supplemented with 10 mM dithiothreitol (DTT). Preheated probe was distributed on each slide, slides Grens/Greenwood/Fernald were coverslipped, and hybridization occurred overnight in a 60°C mineral oil bath. Mineral oil was removed from slides by immersion in chloroform, and unbound and non-specifically hybridized probe was removed by two rinses in 4! SSC (coverslips were removed during second rinse), 10 min in 2! SSC with 10 mM DTT, 30 min in 10 Ìg/ml RNAse A in 2! SSC, 10 min in 2! SSC with DTT, 1 h in 50% formamide and 2! SSC with DTT at 60°C, two-30 min washes in 0.1! SSC at 60°C, 5 min in 0.1! SSC at room temperature, and finally dehydrated in an ethanol series. Slides were dipped in nuclear emulsion (NBT-2; Eastman Kodak) diluted 1:1 in water, air dried, and stored light-free at 4°C for two to three weeks. Exposed slides were processed as follows: 4 min in Kodak D-19 Developer (Eastman Kodak), briefly rinsed in water, 6 min in Kodak Fixer (Eastman Kodak), and rinsed in water. Following emulsion development, slides were stained with cresyl violet, dehydrated in ethanol, immersed in xylenes, and coverslipped with Permount mounting medium (Fisher Scientific, Santa Clara, Calif., USA).
Microscopy
Photomicrographs were taken on a Zeiss Axioscope (Zeiss, Thornwood, N.Y., USA) and recorded digitally using a Spot camera and associated software (Diagnostic Instruments, Sterling Heights, Mich., USA). Images were adjusted to enhance brightness and contrast. In situ hybridization signal was viewed and photographed under both brightfield and darkfield illumination. Brightfield and darkfield images were merged to show both tissue staining and silver grains above cells containing radioactive probe. Our criterion for a labeled cell was a cluster of 1 10 silver grains in a 10 Ìm-diameter circle, as background in areas without cell bodies typically contained less than this density of silver grains. Immunoreactivity was viewed and photographed under fluorescent illumination. Images for dual or triple fluorescent wavelengths were also merged to show nuclear staining and immunoreactivity simultaneously.
Results

GnRH Fibers in the Retina
Terminal nerve fibers in A. burtoni retinas were labeled using an antibody to GnRH3. Varicose fibers extended along the length of the inner plexiform layer (IPL) in close proximity to the amacrine cell layer of the inner nuclear layer (INL; fig. 1A ). Some fibers extended into the INL, although none were observed to delve more than two cell layers deep ( fig. 1B) . In whole, flat-mounted retinas, fibers radiated perpendicular from the optic nerve tract and extended across the retina [data not shown; see Kawamata et al., 1990 for similar results]. Though fibers frequently crossed paths and occasionally ran dorso-ventrally, in general they coursed in a naso-temporal bearing. Fibers hovered just proximal (vitreal) of the INL and inhabited a narrow corridor of roughly 10 Ìm from the edge of the INL into the IPL. Occasionally fibers dipped into planes of INL cells (fig. 1B) . No labeling was evident in or near the ganglion cell layer ( fig. 1C) . Rather, the TN appeared to diverge from the optic nerve at the level of the IPL, and en passant GnRH-positive fibers near the GCL were therefore not observed. Negative controls, which lacked the primary antibody, were not stained (data not shown).
GnRH Receptor Subtypes Are Expressed in Different
Cell Types GnRH-R1. In situ hybridization revealed that the type 1 receptor mRNA was expressed in cells in the amacrine cell layer as demonstrated by the presence of distinct clusters of silver grains above a subset of cells in the vitreal INL ( fig. 2A, C) . GnRH-R1-expressing cells represented only a small percentage of the amacrine cell layer, roughly estimated to be between one and five percent, and were spread somewhat evenly throughout the retina and with no obvious pattern. Signal appeared above cells one or two cell layers scleral of the IPL. The negative control, which was a sense probe made to GnRH-R1 mRNA, showed only random, low-level silver grain placement ( fig. 2B) . Grens/Greenwood/Fernald Cells expressing GnRH-R1 and cells immunoreactive for tyrosine hydroxylase exhibited a very similar distribution. TH antibody labeled a small percentage of cells in the amacrine cell layer, and, as seen in whole-mounted retinas, these cells were distributed throughout the retina but not in a geometric mosaic (fig. 3A) . These cells constituted approximately 1% of the amacrine cell layer. These dopaminergic cells typically inhabited the second cell layer distal (scleral) to the IPL in the INL ( fig. 3B ) and had thick processes extending proximally toward the IPL ( fig. 3C ). When sections were double-labeled for TH and GnRH3, varicose GnRH immunoreactive fibers appeared adjacent to labeled cells, although varicosities were present along the whole INL/IPL border (see fig. 1B ). Negative controls, without the primary antibody for tyrosine hydroxylase, exhibited no labeling (data not shown).
GnRH-R2. The type 2 receptor mRNA was expressed in cells in the ganglion cell layer (fig. 4A ). The in situ hybridization signal was extremely abundant, and it appeared that most, if not all, cells in this layer expressed GnRH-R2. The negative control sense probe produced no such signal ( fig. 4B ).
Discussion
Our description of GnRH immunoreactivity and GnRH receptor expression paints a more definitive picture of where GnRH delivered by the TN could act in the retina of a teleost fish. We have shown that both GnRH receptor types were expressed in the retina and that each is expressed in a different class of cell -type 1 is expressed in a small percentage of cells in the amacrine cell layer, and type 2 is ubiquitously expressed in the ganglion cell layer.
7
The type 1 receptor expression data support the model by Zucker and Dowling [1987] that TN fibers synapse on dopaminergic interplexiform cells in the amacrine cell layer. Our data showed that cells expressing the type 1 receptor and dopaminergic cells exhibited a similar location and distribution pattern. Moreover, GnRH immunoreactive TN fibers were adjacent to the amacrine cell layer and at times extended into this layer, while dopaminergic cells extended processes toward the IPL. We propose that it is the dopaminergic cells that express GnRH-R1. However, without confirmation by doublelabeling, the possibility remains that non-dopaminergic amacrine cells express GnRH-R1 [Kawamata et al., 1990] . Marc [1982] , for example, quantified other cell types in the amacrine cell layer that have a similar distribution as we have shown for GnRH-R1: GABAergic amacrine cells comprise about 2% of the amacrine cell layer, and indoleaminergic cells about 1%. Ball et al. [1989] showed that TN processes appear to make contact with GABAergic amacrine cells, among others. The proposition that type 1 GnRH receptor is expressed in dopaminergic cells is still the most attractive scenario given Umino and Dowling's finding that horizontal cells respond to GnRH application by mimicking the effects of dopamine, suggesting that GnRH acts through dopaminergic interplexiform cells to stimulate dopamine release [Umino and Dowling, 1991] . This hypothesis rests on tyrosine hydroxylase and GnRH-R1 protein being colocalized to the same cells.
The distribution of the type 2 GnRH receptor is quite surprising as retinal ganglion cells were not previously considered a direct target for GnRH3, but rather electrophysiological responses recorded in those cells were believed to reflect a downstream response to activity in interplexiform neurons [Walker and Stell, 1986] . Indeed, retinal ganglion cells are downstream targets of GnRH, as dopaminergic and amacrine cells act upstream of ganglion cells [Dowling and Ehinger, 1978] . However, in addition, we find that the type 2 receptor is widely distributed in the ganglion cell layer. In light of our findings, it is likely that Walker and Stell may have recorded combined effects from both a direct and downstream GnRH target: the retinal ganglion cell. It is unclear whether the receptor might also be expressed in displaced amacrine cells as well as ganglion cells, or whether any cells without signal were obscured by signal in neighboring ganglion cells. There are displaced amacrine cells present in the ganglion cell layer; however, they are thought to be in low abundance (about 2.5% in goldfish [Tumosa and Stell, 1986] ). 
GCL GnRH
It is likely that GnRH3 directly reaches cells possessing the type 1 receptor based on myriad evidence, including our own, that TN fibers course through the INL/IPL interface and based on descriptions of synaptic contacts between TN fibers and cells in this layer [Zucker and Dowling, 1987; Ball et al., 1989] . However, the anatomical connections between ganglion cells and TN fibers are less certain. Although there is evidence for GnRH immunoreactivity near ganglion cells [Stell et al., 1984] and displaced amacrine cells [Ball et al., 1989] in goldfish, we did not find GnRH-positive fibers near the GCL in A. burtoni. Immunolocalization of GnRH receptor type 2 protein on ganglion cells will resolve this issue.
Based on our findings it appears that many cell types of the INL and GCL may be affected -either directly or indirectly -by GnRH. In figure 5 we propose a conceptual model for how GnRH could have such widespread effects in the retina. Given the range of potential influences, it seems clear that GnRH delivered via the TN could modulate visual processing on a large scale. The multiple sites of GnRH influence on visual processing in the retina suggest that this neuromodulator has two important but different effects on visual processing.
First, the GnRH type 1 receptor could impact the flow of lateral information in the retina via dopamine. The demonstration of the roughly uniform distribution of tyrosine hydroxylase-positive (i.e., dopaminergic, see fig. 3A ) neurons hints that there would be widespread delivery of dopamine to its downstream targets. Thus, our data suggest that this pathway could deliver a broadly distributed neuromodulatory effect across the retina to affect the lateral processing of visual information. Dopamine has a considerable effect on visual processing in the retina, and is thought to play a critical role in light adaptation [Djamgoz and Wagner, 1992] , spontaneous ganglion cell activity [see Iuvone, 1986 for review], modulating glutamate receptor sensitivity in horizontal cells [Knapp et al., 1990] , and horizontal-horizontal and rod-cone cell coupling [Krizaj et al., 1998 ]. The evidence of widespread effects of dopamine on multiple aspects of visual processing suggests that GnRH, acting on dopaminergic signaling, could indeed be an important neuromodulator of lateral information flow in the retina.
The second pathway described here involving GnRH type 2 receptors in ganglion cells suggests a more direct role of GnRH in visual processing. Because ganglion cells deliver visual information to the brain, a neuromodulator that affects their processing could have an immediate impact on retinal output. Indeed, the ubiquitous expression of GnRH-R2 mRNA in the ganglion cell layer hints that GnRH modulation could be a very important means of regulating retinal visual output. Taken together, these two mechanisms -lateral and vertical processingthrough which GnRH could influence retinal function might act in a complementary fashion to shape how and what an animal sees.
